Currently, IL-17 has been studied in immune diseases, tumor diseases, and chronic inflammatory diseases, such as multiple sclerosis (MS), rheumatoid arthritis, ankylosing spondylitis, and psoriasis (1). This evidence concerns the gene IL17A and myeloid sarcoma.